Chain Management) New Challenges to Emergency Management of Pharmaceutical/Healthcare Supply Chain Disruptions

Abstract

The continuity of operations in pharmaceutical/healthcare supply chains is vital to human welfare and the span and quality-of-life of patients [1]. This is particularly important when the population is confronted with a massive health problem, such as a breakout of a pandemic (e.g., a deleterious mutation of the swine flu H1N1 virus), an industrial accident (e.g., the release of a massive dose of toxic material in a dense urban area), or a terrorist high-consequence event (e.g., a massive explosion, dirty bomb, or the release of a pathogen into the environment). The continuity of operations could also be affected by data security breaches, demand variability and supply fluctuations. A supply chain disruption occurs when supply falls severely short of supply. Such disruptions take place when either the nominal supply capacity of a business process is greatly reduced for some period of time, or a sudden surge of demand manifests itself, or both. Disruptions in pharmaceutical/healthcare contexts upset the continuity of providing for patient needs, and can have particularly severe consequences. Indeed, when other supply chains are disrupted, companies typically merely lose revenue and potential market share, whereas disruptions to pharmaceutical/healthcare suppl

Similar works

This paper was published in CiteSeerX.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.